Changes in the components of salivary exosomes due to initial periodontal therapy
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Exosomes are membrane vesicles that are present in body fluids and contain proteins, lipids, and microRNA (miRNA). Periodontal tissue examinations assess the degree of periodontal tissue destruction according to the probing depth (PD), clinical attachment loss (CAL), bleeding on probing, and X-ray examinations. However, the accurate evaluation of the prognosis of periodontitis is limited. In this study, we collected saliva from patients before and after initial periodontal therapy (IPT) and compared changes in the clinical parameters of periodontitis with changes in the components of salivary exosomes. Methods: Saliva was collected from patients with stage III and IV periodontitis at the first visit and post-IPT. Exosomes were purified from the saliva, and total protein and RNA were extracted. Changes in expression levels of C6, CD81, TSG101, HSP70, and 6 kinds of miRNA were analyzed by western blots and real-time polymerase chain reaction. Results: Patients with increased C6 expression after IPT had significantly higher levels of periodontal inflamed surface area (PISA), miR-142, and miR-144 before and after IPT than patients with decreased C6 expression after IPT. Patients with decreased and unchanged CD81 expression after IPT showed significantly higher PD, CAL, and PISA before IPT than after IPT. Patients with decreased and unchanged TSG101 expression after IPT had significantly higher PD before IPT than after IPT. Patients with increased HSP70 expression after IPT had significantly higher PD and PISA before and after IPT than patients with unchanged HSP70 after IPT. The expression levels of miR-142, miR-144, miR-200b, and miR-223 changed with changes in the levels of C6, CD81, TSG101, and HSP70 in the salivary exosomes of periodontitis patients before and after IPT. Conclusions: The expression levels of proteins and miRNAs in salivary exosomes significantly changed after IPT in periodontitis patients, suggesting that the components of exosomes could serve as biomarkers for periodontitis.
Abstract
Purpose: Exosomes are membrane vesicles that are present in body fluids and contain proteins, lipids, and microRNA (miRNA). Periodontal tissue examinations assess the degree of periodontal tissue destruction according to the probing depth (PD), clinical attachment loss (CAL), bleeding on probing, and X-ray examinations. However, the accurate evaluation of the prognosis of periodontitis is limited. In this study, we collected saliva from patients before and after initial periodontal therapy (IPT) and compared changes in the clinical parameters of periodontitis with changes in the components of salivary exosomes. Methods: Saliva was collected from patients with stage III and IV periodontitis at the first visit and post-IPT. Exosomes were purified from the saliva, and total protein and RNA were extracted. Changes in expression levels of C6, CD81, TSG101, HSP70, and 6 kinds of miRNA were analyzed by western blots and real-time polymerase chain reaction. Results: Patients with increased C6 expression after IPT had significantly higher levels of periodontal inflamed surface area (PISA), miR-142, and miR-144 before and after IPT than patients with decreased C6 expression after IPT. Patients with decreased and unchanged CD81 expression after IPT showed significantly higher PD, CAL, and PISA before IPT than after IPT. Patients with decreased and unchanged TSG101 expression after IPT had significantly higher PD before IPT than after IPT. Patients with increased HSP70 expression after IPT had significantly higher PD and PISA before and after IPT than patients with unchanged HSP70 after IPT. The expression levels of miR-142, miR-144, miR-200b, and miR-223 changed with changes in the levels of C6, CD81, TSG101, and HSP70 in the salivary exosomes of periodontitis patients before and after IPT. Conclusions: The expression levels of proteins and miRNAs in salivary exosomes significantly changed after IPT in periodontitis patients, suggesting that the components of exosomes could serve as biomarkers for periodontitis.
참고문헌 (40)
- Zheng X, "Exosome analysis : a promising biomarker system with special attention to saliva", J Membr Biol, 247, pp.1129~1136 (2014)
- Vlassov AV, "Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials", Biochim Biophys Acta, 1820, pp.940~948 (2012)
- Huang X, "Analysis of salivary exosomal proteins in young adults with severe periodontitis", Oral Dis, 26, pp.173~181 (2020)
- Lin K, "Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes", Blood Adv, 4, pp.2049~2057 (2020)
- Ma H, "Immune role of the complement component 6 gene and its associated novel miRNA, miR-727, in half-smooth tongue sole (Cynoglossus semilaevis)", Dev Comp Immunol, 123, pp.104156~ (2021)
- Jin Y, "Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging", Sci Rep, 8, pp.5145~ (2018)
- Hemler ME, "Tetraspanin proteins promote multiple cancer stages", Nat Rev Cancer, 14, pp.49~60 (2014)
- Ferraiuolo RM, "The multifaceted roles of the tumor susceptibility gene 101(TSG101)in normal development and disease", Cancers(Basel), 12, pp.450~ (2020)
- Fernández-Fernández MR, "Hsp70 chaperone: a master player in protein homeostasis", F1000 Res, 7, pp.F1000~ (2018)
- Sevin M, "HSP90 and HSP70 : implication in inflammation processes and therapeutic approaches for myeloproliferative neoplasms", Mediators Inflamm, 2015, pp.970242~ (2015)
- Deiuliis JA, "MicroRNAs as regulators of metabolic disease : pathophysiologic significance and emerging role as biomarkers and therapeutics", Int J Obes, 40, pp.88~101 (2016)
- Essandoh K, "MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response", Shock, 46, pp.122~131 (2016)
- Sanz M, "Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guideline", J Clin Periodontol, 47(Suppl 22), pp.4~60 (2020)
- Nik Mohamed Kamal NN, "Plasma-and saliva exosome profile reveals a distinct microRNA signature in chronic periodontitis", Front Physiol, 11, pp.587381~ (2020)
- Fujimori K, "Detection of salivary miRNAs reflecting chronic periodontitis : a pilot study", Molecules, 24, pp.1034~ (2019)
- Wang Y, "Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas", Sci Transl Med, 7, pp.293ra104~ (2015)[DOI]
- Nesse W, "Periodontal inflamed surface area : quantifying inflammatory burden", J Clin Periodontol, 35, pp.668~673 (2008)
- Tobón-Arroyave SI, "Decreased salivary concentration of CD9 and CD81 exosome-related tetraspanins may be associated with the periodontal clinical status", J Clin Periodontol, 46, pp.470~480 (2019)
- Nazir MA, "Prevalence of periodontal disease, its association with systemic diseases and prevention", Int J Health Sci(Qassim), 11, pp.72~80 (2017)
- Bui FQ, "Association between periodontal pathogens and systemic disease", Biomed J, 42, pp.27~35 (2019)
- Maekawa T, "Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis", J Immunol, 192, pp.6020~6027 (2014)
- Sarma JV, "The complement system", Cell Tissue Res, 343, pp.227~235 (2011)
- Damgaard C, "The complement system and its role in the pathogenesis of periodontitis : current concepts", J Periodontal Res, 50, pp.283~293 (2015)
- Morgan BP, "Extrahepatic complement biosynthesis : where, when and why?", Clin Exp Immunol, 107, pp.1~7 (1997)
- Mödinger Y, "Complement involvement in bone homeostasis and bone disorders", Semin Immunol, 37, pp.53~65 (2018)
- Pan W, "The cytokine network involved in the host immune response to periodontitis", Int J Oral Sci, 11, pp.30~ (2019)
- Hajishengallis G, "Complement and periodontitis", Biochem Pharmacol, 80, pp.1992~2001 (2010)
- Raisz LG, "Complement-dependent stimulation of prostaglandin synthesis and bone resorption", Science, 185, pp.789~791 (1974)
- Hasezaki T, "Anti-CD81 antibodies reduce migration of activated T lymphocytes and attenuate mouse experimental colitis", Sci Rep, 10, pp.6969~ (2020)
- Fujii Y, "CD81 inhibition with the cytoplasmic RNA vector producing anti-CD81 antibodies suppresses arthritis in a rat CIA model", Biochem Biophys Res Commun, 604, pp.22~29 (2022)
- Essandoh K, "Tumor susceptibility gene 101 ameliorates endotoxin-induced cardiac dysfunction by enhancing Parkin-mediated mitophagy", J Biol Chem, 294, pp.18057~18068 (2019)
- Onishi M, "Molecular mechanisms and physiological functions of mitophagy", EMBO J, 40, pp.e104705~ (2021)
- Motahari P, "Evaluation of salivary level of heat shock protein 70 in patients with chronic periodontitis", J Dent(Shiraz), 22, pp.175~179 (2021)
- Milani V, "Heat shock protein 70 : role in antigen presentation and immune stimulation", Int J Hyperthermia, 18, pp.563~575 (2002)
- Murase Y, "Salivary extracellular heat shock protein 70(eHSP70)levels increase after 59 min of intense exercise and correlate with resting salivary secretory immunoglobulin A(SIgA)levels at rest", Cell Stress Chaperones, 21, pp.261~269 (2016)
- Li S, "microRNA-142 is upregulated by tumor necrosis factor-alpha and triggers apoptosis in human gingival epithelial cells by repressing BACH2 expression", Am J Transl Res, 9, pp.175~183 (2017)
- Elazazy O, "Evaluation of serum and gingival crevicular fluid microRNA-223, microRNA-203 and microRNA-200b expression in chronic periodontitis patients with and without diabetes type 2", Arch Oral Biol, 121, pp.104949~ (2021)
- Nisha KJ, "Identification of a novel salivary biomarker miR-143-3p for periodontal diagnosis : a proof of concept study", J Periodontol, 90, pp.1149~1159 (2019)
- Xie Z, "Salivary microRNAs as promising biomarkers for detection of esophageal cancer", PLoS One, 8, pp.e57502~ (2013)
- Ogata Y, "MicroRNA expression in inflamed and noninflamed gingival tissues from Japanese patients", J Oral Sci, 56, pp.253~260 (2014)